<ul><li>Biotechnology firm Biocon's board has approved to raise up to Rs 600 crore in one or more tranches on a private placement basis.</li><li>The company's board has approved issuance of commercial papers up to an amount not exceeding Rs 600 crore in one or more tranches on private placement basis.</li><li>The reasons for raising the capital were not disclosed.</li><li>Biocon is a biotechnology firm that focuses on research, development, and manufacturing of innovative and effective pharmaceuticals.</li></ul>

Biocon Board Approves Rs 600 Crore Fundraising Through Private Placement of Commercial Papers

Discover more